The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. owner | XIn-the-money exercise Common Stockindirect: See footnote | -3,539 | $0.00 | $0 | 2,284,612 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. owner | XIn-the-money exercise Common Stockindirect: See footnote | -1,723 | $0.00 | $0 | 1,121,045 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. owner | XIn-the-money exercise Common Stockindirect: See footnote | -1,914 | $0.00 | $0 | 1,226,412 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -3,539 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -1,723 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -1,914 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Ran Nussbaum director, owner | XIn-the-money exercise Common Stockindirect: See footnote | -3,539 | $0.00 | $0 | 2,284,612 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Ran Nussbaum director, owner | XIn-the-money exercise Common Stockindirect: See footnote | -1,723 | $0.00 | $0 | 1,121,045 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Ran Nussbaum director, owner | XIn-the-money exercise Common Stockindirect: See footnote | -1,914 | $0.00 | $0 | 1,226,412 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Ran Nussbaum director, owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -3,539 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Ran Nussbaum director, owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -1,723 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Ran Nussbaum director, owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -1,914 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Tomer Kariv director, owner | XIn-the-money exercise Common Stockindirect: See footnote | -3,539 | $0.00 | $0 | 2,284,612 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Tomer Kariv director, owner | XIn-the-money exercise Common Stockindirect: See footnote | -1,723 | $0.00 | $0 | 1,121,045 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Tomer Kariv director, owner | XIn-the-money exercise Common Stockindirect: See footnote | -1,914 | $0.00 | $0 | 1,226,412 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Tomer Kariv director, owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -3,539 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Tomer Kariv director, owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -1,723 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 29, 2022 | KROS Keros Therapeutics, Inc. | Tomer Kariv director, owner | XIn-the-money exercise Call Options (obligation to sell)derivativeindirect: See footnote | -1,914 | $0.00 | $0 | 0 | Nov 30, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | Douglas J. Hughes director | XIn-the-money exercise Common Stock | +71,363 | $0.50 | $36k | 107,072 | Nov 25, 2022 |
| Nov 23, 2022 | EAR Eargo, Inc. | Douglas J. Hughes director | XIn-the-money exercise Subscription Rights (right to buy)derivative | -7,500 | $0.00 | $0 | 0 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | Adam Laponis Chief Financial Officer | XIn-the-money exercise Common Stock | +4,995 | $0.50 | $2,498 | 64,222 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | Adam Laponis Chief Financial Officer | XIn-the-money exercise Subscription Rights (right to buy)derivative | +525 | $0.00 | $0 | 0 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | Mark Thorpe Chief Accounting Officer | XIn-the-money exercise Common Stock | +2,521 | $0.50 | $1,261 | 21,481 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | Mark Thorpe Chief Accounting Officer | XIn-the-money exercise Subscription Rights (right to buy)derivative | -265 | $0.00 | $0 | 0 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | David James Wu director | XIn-the-money exercise Common Stock | +173,812 | $0.50 | $87k | 192,079 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | David James Wu director | XIn-the-money exercise Common Stock | +307,921 | $0.50 | $154k | 500,000 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | David James Wu director | XIn-the-money exercise Common Stockindirect: See Footnote | +8,382 | $0.50 | $4,191 | 9,263 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | David James Wu director | XIn-the-money exercise Subscription Rights (right to buy)derivative | -18,267 | $0.00 | $0 | 0 | Nov 25, 2022 |
| Nov 22, 2022 | EAR Eargo, Inc. | David James Wu director | XIn-the-money exercise Subscription Rights (right to buy)derivativeindirect: See Footnote | -881 | $0.00 | $0 | 0 | Nov 25, 2022 |
| Nov 21, 2022 | MYO MYOMO, INC. | Paul R Gudonis Chief Executive Officer | XIn-the-money exercise Common Stock | +333 | $0.00 | $0 | 175,653 | Nov 23, 2022 |
| Nov 21, 2022 | MYO MYOMO, INC. | Paul R Gudonis Chief Executive Officer | XIn-the-money exercise Warrantsderivative | -333 | $0.00 | $0 | 0 | Nov 23, 2022 |
| Nov 17, 2022 | ATEC Alphatec Holdings, Inc. | L-5 Healthcare Partners, LLC owner, other | XIn-the-money exercise Warrants to Purchase Common Stockderivative | -1,000,000 | $0.00 | $0 | 4,346,032 | Nov 18, 2022 |
| Nov 17, 2022 | ARTNA ARTESIAN RESOURCES CORP | Kenneth R Biederman director | XIn-the-money exercise Class A Non-voting Common Stock | +3,396 | $21.86 | $74k | 26,271 | Nov 18, 2022 |
| Nov 17, 2022 | ARTNA ARTESIAN RESOURCES CORP | Kenneth R Biederman director | XIn-the-money exercise Non-qualified Stock Option (Right to Buy)derivative | -3,396 | $0.00 | $0 | 0 | Nov 18, 2022 |
| Nov 14, 2022 | - BlackRock Direct Lending Corp. | Institution for Social Security Public owner | XIn-the-money exercise Common Stock, $0.001 par value | +2,871,008 | $10.44 | $30M | 17,401,571 | Nov 16, 2022 |
| Nov 14, 2022 | - BlackRock Direct Lending Corp. | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -2,871,008 | - | - | 0 | Nov 16, 2022 |
| Nov 11, 2022 | CPSH CPS TECHNOLOGIES CORP/DE/ | Ralph M Norwood director | XIn-the-money exercise Common Stock | +20,000 | $1.00 | $20k | 41,325 | Nov 15, 2022 |
| Nov 11, 2022 | CPSH CPS TECHNOLOGIES CORP/DE/ | Ralph M Norwood director | XIn-the-money exercise Common Stock Optionsderivative | -20,000 | $1.00 | $20k | 143,100 | Nov 15, 2022 |
| Nov 10, 2022 | CHPT ChargePoint Holdings, Inc. | Rex S Jackson Chief Financial Officer | XIn-the-money exercise Common Stockindirect: By trust | +87,821 | $6.03 | $530k | 197,335 | Nov 14, 2022 |
| Nov 10, 2022 | CHPT ChargePoint Holdings, Inc. | Rex S Jackson Chief Financial Officer | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By trust | -87,821 | $0.00 | $0 | 0 | Nov 14, 2022 |
| Nov 9, 2022 | ATEC Alphatec Holdings, Inc. | L-5 Healthcare Partners, LLC owner, other | XIn-the-money exercise Warrants to Purchase Common Stockderivative | -1,000,000 | $0.00 | $0 | 5,346,032 | Nov 10, 2022 |
| Jan 26, 2021 | DMTK DermTech, Inc. | Rtw Investments, LP owner | XIn-the-money exercise Common Stockindirect: See footnote | +31,450 | $9.54 | $300k | 3,118,666 | Nov 8, 2022 |
| Jan 26, 2021 | DMTK DermTech, Inc. | Rtw Investments, LP owner | XIn-the-money exercise Warrants to Purchase Common Stockderivativeindirect: See footnote | -31,450 | $9.54 | $300k | 0 | Nov 8, 2022 |
| Oct 25, 2022 | VERX Vertex, Inc. | Tensile Capital Management LP owner | XIn-the-money exercise Class A common stockindirect: By Tensile Capital Partners Master Fund LP | +750,000 | $7.85 | $5.9M | 5,970,258 | Oct 27, 2022 |
| Oct 25, 2022 | VERX Vertex, Inc. | Tensile Capital Management LP owner | XIn-the-money exercise Stock Option (Right to Buy)derivative | -1 | $0.00 | $0 | 0 | Oct 27, 2022 |
| Oct 26, 2022 | VERX Vertex, Inc. | Jeffery Westphal owner | XIn-the-money exercise Class A Common Stockindirect: By The 2009 Jeffrey R. Westphal Generation Skipping Trust | -750,000 | $7.85 | $5.9M | 10,550,000 | Oct 26, 2022 |
| Oct 26, 2022 | VERX Vertex, Inc. | Jeffery Westphal owner | XIn-the-money exercise Call Option (Obligation to Sell)derivativeindirect: By The 2009 Jeffrey R. Westphal Generation Skipping Trust | -750,000 | $0.00 | $0 | 0 | Oct 26, 2022 |
| Oct 21, 2022 | SEAC SEACHANGE INTERNATIONAL INC | Karen Singer owner | XIn-the-money exercise Common Stockindirect: LLC managing member | +204,400 | $1.00 | $204k | 8,431,970 | Oct 24, 2022 |
| Oct 21, 2022 | SEAC SEACHANGE INTERNATIONAL INC | Karen Singer owner | XIn-the-money exercise Put Optionsderivativeindirect: LLC Managing Member | -250 | - | - | 0 | Oct 24, 2022 |
| Oct 21, 2022 | SEAC SEACHANGE INTERNATIONAL INC | Karen Singer owner | XIn-the-money exercise Put Optionsderivativeindirect: LLC Managing Member | -494 | - | - | 0 | Oct 24, 2022 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.